Home › Kanker (alle vormen) › Utah › Salt Lake City
Kanker (alle vormen) klinische studies in Salt Lake City, UT
27 studies voor Kanker (alle vormen) zoeken deelnemers op locaties in en rond Salt Lake City (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
RekruterenFase 1/2
- Intermountain - Primary Children's Hospital ( Site 4014), Salt Lake City
SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer Care
Rekruteren
- Huntsman Cancer Institute/ University of Utah, Salt Lake City
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
RekruterenFase 3
- Utah Cancer Specialists Cancer Center - Medical Oncology, Salt Lake City
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekruterenFase 2
- Intermountain Healthcare, Salt Lake City
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
RekruterenFase 2/3
- University of Utah - Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare - LDS Hospital, Salt Lake City
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
RekruterenFase 1/2
- Intermountain - Primary Children's Hospital ( Site 3014), Salt Lake City
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RekruterenFase 2
- Huntsman Cancer Institute - University of Utah Health, Salt Lake City
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
RekruterenFase 1/2
- Huntsman Cancer Institute /ID# 271618, Salt Lake City
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
RekruterenFase 1/2
- Huntsman Cancer Institute, Salt Lake City
Project: Every Child for Younger Patients With Cancer
RekruterenObservatieonderzoek
- Primary Children's Hospital, Salt Lake City
Abatacept in Immune Checkpoint Inhibitor Myocarditis
RekruterenFase 3
- University of Utah, Salt Lake City
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruterenFase 3
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
RekruterenFase 1/2
- Huntsman Cancer Institute /ID# 272575, Salt Lake City
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RekruterenFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
Rekruteren
- Huntsman Cancer Institute at The University of Utah, Salt Lake City
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Rekruteren
- VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City
Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
Rekruteren
- University of Utah Huntsman Cancer Institute (HCI), Salt Lake City
- University of Utah Primary Children's Hospital, Salt Lake City
Galleri® in the Medicare Population.
RekruterenGezonde vrijwilligers welkom
- HCA Healthcare St. Marks, Salt Lake City
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekruterenFase 2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Rekruteren
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Improving Health Insurance Literacy Among Young Adult Cancer Survivors
Rekruteren
- University of Utah, Salt Lake City
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RekruterenFase 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
Rekruteren
- Huntsman Cancer Institute, Salt Lake City
Childhood Cancer Predisposition Study (CCPS)
RekruterenObservatieonderzoek
- Primary Children's Hospital, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Salt Lake City
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
RekruterenObservatieonderzoek
- Utah Cancer Specialists, Salt Lake City
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Rekruteren
- Huntsman Cancer Institute (The University of Utah), Salt Lake City
Kanker (alle vormen) studies in andere steden
- Houston, TX121 studies
- New York City, NY109 studies
- Boston, MA85 studies
- Los Angeles, CA74 studies
- Nashville, TN65 studies
- Philadelphia, PA59 studies
- Washington, DC58 studies
- Durham, NC58 studies
- Chicago, IL51 studies
- Atlanta, GA49 studies
- Seattle, WA49 studies
- Arlington, VA48 studies
Andere studies in Salt Lake City
- Niet-kleincellige longkanker31 studies
- Borstkanker27 studies
- Colorectale kanker22 studies
- Longkanker21 studies
- Melanoom21 studies
- Multipel myeloom21 studies
- Metastatische kanker20 studies
- Eierstokkanker19 studies
- Obesitas18 studies
- Acute myeloïde leukemie17 studies
- Hartfalen17 studies
- Prostaatkanker15 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.